Fig 4.
Representative radiochromatograms of plasma, urine, and feces after a single oral 20-mg (80-μCi) dose of [14C]dolutegravir to an individual healthy male subject. (A) Plasma at 24 h. (B) Urine at 0 to 72 h. (C) Feces at 0 to 96 h.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.